Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Tata Nifty MidSmall Healthcare Index Fund Direct Growth
NAV: 20 Jul '26
₹15.05
Min. for SIP
₹100
Fund size (AUM)
₹182.18 Cr
Expense ratio
0.55%
Rating
--
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,696 | +4.64% | |
| 6 months | ₹30,000 | ₹33,456 | +11.52% | |
| 1 year | ₹60,000 | ₹68,197 | +13.66% |
Holdings (32)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Laurus Labs Ltd | Healthcare | Equity | 9.36% |
| Lupin Ltd | Healthcare | Equity | 9.30% |
| Fortis Healthcare Ltd | Healthcare | Equity | 7.90% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 6.99% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 5.26% |
| Alkem Laboratories Ltd | Healthcare | Equity | 5.17% |
| Biocon Ltd | Healthcare | Equity | 4.73% |
| Mankind Pharma Ltd. | Healthcare | Equity | 4.56% |
| Ipca Laboratories Ltd | Healthcare | Equity | 3.74% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 3.19% |
| Gland Pharma Ltd | Healthcare | Equity | 3.15% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 3.15% |
| JB Chemicals & Pharmaceuticals Ltd | Healthcare | Equity | 2.98% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 2.69% |
| Neuland Laboratories Ltd | Healthcare | Equity | 2.54% |
| Wockhardt Ltd | Healthcare | Equity | 2.54% |
| Ajanta Pharma Ltd | Healthcare | Equity | 2.28% |
| Narayana Hrudayalaya Ltd | Healthcare | Equity | 2.16% |
| Abbott India Ltd | Healthcare | Equity | 2.10% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 2.03% |
| Granules India Ltd | Healthcare | Equity | 1.87% |
| Global Health Ltd | Healthcare | Equity | 1.76% |
| Piramal Pharma Ltd | Healthcare | Equity | 1.65% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 1.61% |
| Onesource Specialty Pharma Ltd | Healthcare | Equity | 1.44% |
| Syngene International Ltd | Healthcare | Equity | 1.32% |
| Natco Pharma Ltd | Healthcare | Equity | 1.32% |
| Suven Pharmaceuticals Ltd | Healthcare | Equity | 1.18% |
| Pfizer Ltd | Healthcare | Equity | 1.07% |
| Poly Medicure Ltd | Healthcare | Equity | 1.02% |
| Repo | Unspecified | Repo | 0.07% |
| Net Payables | Unspecified | Net Payables | -0.13% |
See All
Minimum investments
Min. for 1st investment
₹5,000
Min. for 2nd investment
₹1,000
Min. for SIP
₹100
Returns and rankings
Annualised returns
Absolute returns
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +14.6% | +17.0% | +11.7% | +49.3% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 11 | 10 | 10 | -- |
Exit load, stamp duty and tax
Exit load
Exit load of 0.25%, if redeemed within 15 days.
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
NBSNitin Bharat SharmaJul 2025 - PresentView details
NBS
Nitin Bharat Sharma
Jul 2025 - Present
View details
RPRakesh PrajapatiDec 2024 - PresentView details
RP
Rakesh Prajapati
Dec 2024 - Present
View details
About Tata Nifty MidSmall Healthcare Index Fund Direct Growth
Tata Nifty MidSmall Healthcare Index Fund Direct Growth is a Equity Mutual Fund Scheme launched by Tata Mutual Fund. This scheme was made available to investors on 30 Jun 1995. Nitin Bharat Sharma is the Current Fund Manager of Tata Nifty MidSmall Healthcare Index Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹2,17,682 Cr and the Latest NAV as of 20 Jul 2026 is ₹15.05.
The Tata Nifty MidSmall Healthcare Index Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹5,000. Exit load of 0.25%, if redeemed within 15 days.
;
Investment Objective
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
Fund benchmarkNifty MidSmall Healthcare Total Return Index
Fund house
Rank (total assets)#14 in India
Total AUM₹2,17,681.90 Cr
Date of Incorporation30 Jun 1995
Launch Date30 Jun 1995
Address9th Floor, Mafatlal Centre,Nariman Point, Mumbai 400021
Websitewww.camsonline.com
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,